Please find our attached intimation on the captioned subject.
VALIANTORG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Valiant Organics reported a strong turnaround in FY26 with revenue of INR 7,388 Mn (up 2.8% YoY) and EBITDA margin expanding sharply to 11.94% from 7.47% in FY25, a gain of 447 basis points. The company attributed this to 'structural cost optimization initiatives' including raw material optimization and tighter overhead control. PAT turned positive at INR 332 Mn versus a loss of INR 34 Mn in FY25. Q4 standalone performance was also strong with revenue of INR 2,178 Mn (up 6.9% YoY) and EBITDA margin of 12.17%. Finance costs declined 22.9% YoY to INR 182 Mn. The company remains a major chlorophenol derivatives and PNA manufacturer with 70,000 TPA capacity across 6 manufacturing units.
The margin expansion and return to profitability represent a significant turnaround and are positive for shareholders. The structural nature of cost improvements suggests sustainable profitability gains, though the stock has underperformed the Sensex over the past year.